Cargando…

Blood and CSF Biomarker Dynamics in Multiple Sclerosis: Implications for Data Interpretation

Background. Disability in multiple sclerosis (MS) is related to neuroaxonal degeneration. A reliable blood biomarker for neuroaxonal degeneration is needed. Objectives. To explore the relationship between cerebrospinal fluid (CSF) and serum concentrations of a protein biomarker for neuroaxonal degen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Eikelenboom, M. J., Uitdehaag, B. M. J., Petzold, A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195856/ https://www.ncbi.nlm.nih.gov/pubmed/22096644 http://dx.doi.org/10.1155/2011/823176

Ejemplares similares

Retinal inter-eye difference and atrophy progression in multiple sclerosis diagnostics
por: Nij Bijvank, Jenny, et al.
Publicado: (2022)

Inflammation-related plasma and CSF biomarkers for multiple sclerosis
por: Huang, Jesse, et al.
Publicado: (2020)

Emerging Biomarkers of Multiple Sclerosis in the Blood and the CSF: A Focus on Neurofilaments and Therapeutic Considerations
por: Biernacki, Tamás, et al.
Publicado: (2022)

Diagnosing and quantifying a common deficit in multiple sclerosis: Internuclear ophthalmoplegia
por: Nij Bijvank, J.A., et al.
Publicado: (2019)

N-acetylaspartic acid in cerebrospinal fluid of multiple sclerosis patients determined by gas-chromatography-mass spectrometry
por: Jasperse, Bas, et al.
Publicado: (2007)

Real-world keystroke dynamics are a potentially valid biomarker for clinical disability in multiple sclerosis
por: Lam, KH, et al.
Publicado: (2020)

Osteopontin (OPN) as a CSF and blood biomarker for multiple sclerosis: A systematic review and meta-analysis
por: Agah, Elmira, et al.
Publicado: (2018)

Posttranslational modifications of proteins are key features in the identification of CSF biomarkers of multiple sclerosis
por: Salazar, Ivan L., et al.
Publicado: (2022)

CSF isoprostane levels are a biomarker of oxidative stress in multiple sclerosis
por: Mir, Fozia, et al.
Publicado: (2014)

Grey Matter Atrophy in Multiple Sclerosis: Clinical Interpretation Depends on Choice of Analysis Method
por: Popescu, Veronica, et al.
Publicado: (2016)

Decision tree supports the interpretation of CSF biomarkers in Alzheimer's disease
por: Babapour Mofrad, Rosha, et al.
Publicado: (2018)

Structure‐function relationships in the visual system in multiple sclerosis: an MEG and OCT study
por: Tewarie, Prejaas, et al.
Publicado: (2017)

CSF Cytokines in Aging, Multiple Sclerosis, and Dementia
por: Hu, William T., et al.
Publicado: (2019)

Cognitive impairment in patients with multiple sclerosis is associated with atrophy of the inner retinal layers
por: Coric, Danko, et al.
Publicado: (2017)

The association between blood MxA mRNA and long-term disease activity in early multiple sclerosis
por: Coerver, Eline M. E., et al.
Publicado: (2022)

Disability Outcome Measures in Phase III Clinical Trials in Multiple Sclerosis
por: Uitdehaag, Bernard M. J.
Publicado: (2018)

Feasibility of the Use of Combinatorial Chemokine Arrays to Study Blood and CSF in Multiple Sclerosis
por: Edwards, Keith R., et al.
Publicado: (2013)

Regulation of CSF and Brain Tissue Sodium Levels by the Blood-CSF and Blood-Brain Barriers During Migraine
por: Ghaffari, Hamed, et al.
Publicado: (2020)

Retinal atrophy in relation to visual functioning and vision-related quality of life in patients with multiple sclerosis
por: Balk, Lisanne J, et al.
Publicado: (2017)

Circulating miR-150 in CSF is a novel candidate biomarker for multiple sclerosis
por: Bergman, Petra, et al.
Publicado: (2016)

Outcome Measures in Clinical Trials for Multiple Sclerosis
por: van Munster, Caspar E. P., et al.
Publicado: (2017)

A novel eye-movement impairment in multiple sclerosis indicating widespread cortical damage
por: Nij Bijvank, Jenny A, et al.
Publicado: (2022)

Variability of CSF Alzheimer’s Disease Biomarkers: Implications for Clinical Practice
por: Vos, Stephanie J. B., et al.
Publicado: (2014)

CSF and blood biomarkers in amyotrophic lateral sclerosis: protocol for a systematic review and meta-analysis
por: Agah, Elmira, et al.
Publicado: (2018)

A model for interrogating the clinico‐radiological paradox in multiple sclerosis: Internuclear ophthalmoplegia
por: Nij Bijvank, Jenny A., et al.
Publicado: (2021)

Elevated CSF histamine levels in multiple sclerosis patients
por: Kallweit, Ulf, et al.
Publicado: (2013)

Consensus Guidelines for CSF and Blood Biobanking for CNS Biomarker Studies
por: Teunissen, Charlotte E., et al.
Publicado: (2011)

Global alterations to the choroid plexus blood-CSF barrier in amyotrophic lateral sclerosis
por: Saul, J., et al.
Publicado: (2020)

Objective quantification of vitreous haze on optical coherence tomography scans: no evidence for relationship between uveitis and inflammation in multiple sclerosis
por: Coric, D., et al.
Publicado: (2019)

Longitudinal Development of Peripapillary Hyper‐Reflective Ovoid Masslike Structures Suggests a Novel Pathological Pathway in Multiple Sclerosis
por: Petzold, Axel, et al.
Publicado: (2020)

Chitinase-3-like 1-protein in CSF: a novel biomarker for progression in patients with multiple sclerosis
por: Talaat, Foraysa, et al.
Publicado: (2023)

Clinical, MRI, and CSF Markers of Disability Progression in Multiple Sclerosis
por: Gajofatto, Alberto, et al.
Publicado: (2013)

Immunodetection of oligoclonal bands in serum and CSF of Multiple Sclerosis patients
Publicado: (2015)

Quantified CSF antibody reactivity against myelin in multiple sclerosis
por: Sun, Xingwen, et al.
Publicado: (2015)

Leveraging real-world data to investigate multiple sclerosis disease behavior, prognosis, and treatment
por: Cohen, Jeffrey A, et al.
Publicado: (2019)

Increase of CSF inflammatory profile in a case of highly active multiple sclerosis
por: Magliozzi, R., et al.
Publicado: (2019)

Arterial spin labeling signal in the CSF: Implications for partial volume correction and blood–CSF barrier characterization
por: Petitclerc, Léonie, et al.
Publicado: (2022)

Impaired saccadic eye movements in multiple sclerosis are related to altered functional connectivity of the oculomotor brain network
por: Nij Bijvank, J.A., et al.
Publicado: (2021)

CSF Free Light Chains as a Marker of Intrathecal Immunoglobulin Synthesis in Multiple Sclerosis: A Blood-CSF Barrier Related Evaluation in a Large Cohort
por: Senel, Makbule, et al.
Publicado: (2019)

Biopsychosocial implications of living with multiple sclerosis: a qualitative study using interpretative phenomenological analysis
por: Kassie, Seada A, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_cv484g83b4ce5do8oj0drftkmg